SeraCare Life Sciences SRLS announced today the addition of differentiated Cryo-M Human Monocytes to their AccuCell™ peripheral blood mononuclear cell portfolio. SeraCare's Cryo-M cells provide researchers
with a high quality, specialized and unstimulated cell line to study gene expression, immune and inflammatory responses. This product is manufactured from standardized, quality-controlled sole source lots, allowing for
consistent and reproducible results. This is the third in a series of new cellular products and the twenty-first new product introduced to SeraCare's overall portfolio over the last 18 months.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in